HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral treatment with a Brachystemma calycinum D don plant extract reduces disease symptoms and the development of cartilage lesions in experimental dog osteoarthritis: inhibition of protease-activated receptor 2.

AbstractOBJECTIVE:
The aims of this study were to evaluate the effect of oral treatment with a whole plant extract of Brachystemma calycinum D don (BCD) on the development of osteoarthritic lesions and symptoms in the experimental dog anterior cruciate ligament (ACL) transection model and to document its mechanism of action.
METHODS:
Osteoarthritis was induced by sectioning the ACL of the right knee in crossbred dogs. There were two experimental groups (n=6-7 dogs/group): placebo and BCD extract (200 mg/kg per day) given orally for 8 weeks. Macroscopic and histopathological evaluation of cartilage lesions and immunohistochemical analysis of cartilage to assess levels of inducible nitric oxide synthase (iNOS), matrix metalloprotease 13 (MMP-13) and protease activated receptor 2 (PAR-2) were done. A gait analysis of dogs was performed.
RESULTS:
Treatment with BCD reduced the severity (depth) (p=0.04) and histopathological score (p<0.02) of osteoarthritis cartilage lesions. BCD treatment also significantly reduced the osteoarthritis chondrocyte level of key inflammatory and catabolic factors (iNOS, p=0.009 and MMP-13, p=0.003) as well as the level of PAR-2 (p=0.03). Dogs treated with BCD showed a significant improvement in peak vertical force measured at 8 weeks (p<0.05).
CONCLUSIONS:
Treatment with BCD extract exerts a positive effect on the prevention of cartilage lesions induced by joint instability, and improves joint function. This effect was associated with the inhibition of major catabolic and inflammatory mediators. This study is the first to demonstrate that a therapeutic intervention that can inhibit PAR-2 is associated with a disease-modifying osteoarthritis effect.
AuthorsChristelle Boileau, Johanne Martel-Pelletier, Judith Caron, Frédéric Paré, Eric Troncy, Maxim Moreau, Jean-Pierre Pelletier
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 69 Issue 6 Pg. 1179-84 (Jun 2010) ISSN: 1468-2060 [Electronic] England
PMID19546097 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Plant Extracts
  • Receptor, PAR-2
Topics
  • Administration, Oral
  • Animals
  • Arthritis, Experimental (metabolism, pathology, prevention & control)
  • Cartilage, Articular (metabolism, pathology)
  • Caryophyllaceae
  • Dogs
  • Drug Evaluation, Preclinical (methods)
  • Gait
  • Osteoarthritis (metabolism, pathology, prevention & control)
  • Phytotherapy (methods)
  • Plant Extracts (pharmacology, therapeutic use)
  • Receptor, PAR-2 (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: